Carboplatin is a neoplastic agent causing hematotoxicity, erythropoietin (EPO) resistance, increase oxidative stress and pro-inflammatory cytokines. Our study investigated the role of erythropoietin, vitamin C and L-NAME in carboplatin-induced hematological and renal dysfunctions. Seventy rats divided into seven groups; control, Carboplatin (100 mg/kg.), Carboplatin (250 mg/kg), Carboplatin (100 mg/kg.) pretreated by EPO , Carboplatin (250 mg/kg) pretreated by EPO, Carboplatin ( 250 mg/kg ) pretreated by EPO & Vitamin C and Carboplatin (250 mg/kg) pretreated by EPO & L-NAME. Hematological, plasma inflammatory cytokines, renal functions , oxidant, antioxidant parameters , serum EPO and vitamin C were measured with histopathology of renal tissue. Carboplatin decreased RBC count, hemoglobin concentration, packed cells volume, platelets count , superoxide dismutase , catalase and glutathione peroxidase, serum erythropoietin and vitamin C while WBCs count, interleukin 1, interleukin 6, tumor necrosis factor alpha, high-sensitivity C-reactive protein, serum blood urea nitrogen, serum creatinine, malondialdehyde and nitric oxide were increased. Vitamin C and L-NAME improved hematological derangement, EPO resistance, antioxidant parameters and histopathological findings while worsen plasma inflammatory markers, renal functions parameters and oxidative parameters. There was insignificant change in blood indices in all groups. We concluded that carboplatin had a hematological toxicity and oxidant stress effect in addition to increase proinflammatory cytokines and consequent renal insult. The development of EPO resistance was carboplatindose dependent . Vitamin C and L-NAME alleviate the hematological toxicity, oxidative stress, EPO resistance and decrease proinflammatory cytokines and in turn recovery of renal structure and functions.
INTRODUCTION
The chemotherapeutic agents have many complications such as hematological and immunological derangements as well as renal dysfunctions [1] . Carboplatin is one of platinumcontaining chemotherapeutic drugs and alkylating agents. Administration of carboplatin is associated with dose-related myelosuppression resulting in anemia, thrombocytopenia and renal dysfunctions [2] . Several mechanisms have been postulated to explain the mechanisms underlying the carboplatin -induced toxicities such as production of reactive oxygen species (ROS), nitric oxide (NO) [3] and proinflammatory cytokines e.g. interleukin-1 (IL-1), interleukin-6 (IL-6) and tumor necrosis factor-α (TNFα) [4] .
The immunosuppressive action of carboplatin results in excessive production of reactive O2 species (ROS) formed by myeloid cells was revealed by many studies [5] , which cause auto-oxidation of hemoglobin (Hb) and
RBCs damage [2] . Also, nitric oxide (NOx), which is a diffusible free radical generated primarily by the action of NOx synthases (NOS) on L-arginine, inhibits the growth, differentiation, and hemoglobinization of erythroid primary cells.
Moreover, the bioactivity of nitric oxide synthases (NOS) mRNA decreases during normal erythropoiesis [6] . So the L-NAME (Nitro-Larginine methyl ester), a non-selective inhibitor of nitric oxide synthase, was administered in this study to clarify this effect. Cytokines, which are produced by many types of cells such as macrophages, lymphocytes, and mast cells, endothelial cells, fibroblasts, and various stromal cells and play an important role in modulation of the functions of individual cells under normal and pathological conditions [7] . Pro-inflammatory cytokines, such as IL-1, IL-6 and TNF-α can modulate erythropoiesis and may play a role in pathogenesis of carboplatin -induced anemia [2] via stimulation of apoptotic process in erythropoietic stem cells. Furthermore, the carboplatin-induced elevation in IL-6 levels causes production of high sensitive C-reactive protein (hsCRP) by liver cells a protein, which activates the complement system. Serum hsCRP concentrations can be used to assess the antioxidant concentrations, which have inverse relation to it [9] .
Erythropoietin (EPO), the main regulator of RBCs production, is produced mainly by the kidney (renal peritubular fibroblasts) and to less extent the liver, testis, uterus, skeletal muscles, lungs, and brain [10] . Previous studies had revealed that EPO exerts multiple protective effects, including anti-oxidative [11] , antiinflammatory [12] and anti-apoptotic effects [13] Interestingly, Leyland-Jones [14] suggested that erythropoietin is commonly used to induce hematopoietic recovery after chemotherapy. In some cases, there is a development of resistance to EPO, which could be attributed to production of certain inflammatory cytokines, primarily macrophage-derived, including IL-l, IL-6 and TNF-α. Moreover, studies by Michelle et al. [15] have shown that administration of EPO can either partially or completely correct the chemotherapy induced -anemia in patients with blocked response to EPO. On other hand, previous study demonstrated that carboplatininduced inflammation causes resistance of the bone marrow to action of erythropoietin (EPO) causing anemia in a dose dependent manner [8] . On the other hand, vitamin C (ascorbic acid) is an important water-soluble nutrient involved in vital functions within cells, including facilitation of iron transport [16] as well as being one of the most important physiological antioxidants acting on host defense mechanisms assuring immune balance [17] .
Vitamin C, a potent antioxidant, has both a preventative and therapeutic role in a number of pathologies when administered at much higherthan-recommended dietary allowance levels, including cancer [18] . It was also revealed that vitamin C alleviates inflammatory reactions [19] .
Moreover, there is a limited information about the effects of vitamin C on the production of cytokines. Calder et al. [20] suggested that vitamin C inhibited production of IL-6 and TNF-α in monocytes. Furthermore, Tan et al. [21] reported that vitamin C alleviated oxidative stress and proinflammatory mediators since, inflammation plays a major role in the development of EPO resistance. So, in the present study, we investigated the role of erythropoietin , vitamin C and L-NAME in carboplatin-induced hematological and renal dysfunctions.
Materials & Methods

Experimental Animals
Seventy 
Experimental design
Experimental rats were divided into 7 groups as consist of 10 rats in each group as follow; 
Assay of plasma cytokines (IL-1, IL-6 and TNFalpha)
Plasma was assayed for the proinflammatory 
Assay of markers of oxidative stress in serum
The levels of serum MDA , SOD, CAT and 
Assay of kidney functions parameters
To monitor and examine the effects of treatment on renal function, blood was collected on day 7
and serum BUN and serum creatinine were measured using a Beckman BUN analyzer II and Sigma creatinine kit 555, respectively [30] . 
Assay of serum erythropoietin
Statistical analysis
Data were processed and analyzed using the Statistical Package of Social Science version 10.0 (SPSS, version 10.0). The data were expressed as mean ± standard error of mean (Mean ± SEM).
One-way ANOVA analysis of data was done followed by Tukey's posthoc test. A minimum level of significance is considered if p<0.05.
Results
Animal survival
By the end of experiment, five rats died during the experiment. The final numbers were, group I=10, group II=9, group III=8, group IV=10, group V=8, group VI=10 animals and group VII=10. VII showed a significant decrease in all parameters as compared to group V (P <0.001). VII). Figure 4 Sections of the kidneys demonstrated that group I (control group) had normal structure of the kidney with the renal corpuscles, proximal and distal convoluted tubules ( Fig. 3 . I). The renal cortices of group II showed marked pathological changes in the form of patches of necrosis with widening of the Bowman's spaces and vaccuolation of the cytoplasm of the renal tubules ( Fig. 3 . II). Group III had no areas of focal necrosis but bowmans spaces still showing apparent widening. The renal tubular cell lining had less marked signs of degeneration ( Fig.3 .III). Group IV had more extensive pathological changes with patchy necrosis and widening of the Bowman's spaces. Most of the cell lining of the renal tubules appeared distended with occlusion of the renal tubular lumen ( Fig.3 .IV). Group V showed near normal structure of the glomeruli but the renal tubules showed widened lumens with vacculation of the cellular lining ( Fig.3. V) . Group VI had almost normal renal corpuscles but still the renal tubules had wider lumens ( Fig.3 . VI). Finally group VII had a very close picture of normality in both the renal corpuscles and tubules ( Fig.3 . VII) (Hx & E x400).
Hematological parameters
Inflammatory cytokines
Kidney morphology
Discussion
The present study revealed that production, while having no effect on IL-1 levels [57] . Also, it has been shown that vitamin C inhibit granulocyte-macrophage-colony-stimulating factor (GM-CSF)-, IL-3-and IL-5-induced signal transduction pathways [57] . Vitamin C could modulate the immune system by inhibiting T cell and monocytes apoptosis signaling pathways and by turn inhibit production of inflammatory mediators and modulate cytokine levels(IL-6 and TNF-α) in Carboplatin -induced toxicity [59] . In addition ,it was also reported that vitamin C caused a significantly decrease mRNA levels of IL-6 and TNF-α produced by liver in the stressed rats besides its antioxidant property [57] .These .This intercellular signaling molecule is important for the immune system, as well as generating free oxygen radicals called peroxynitrites (ONOO − ), as a result of combination of NOx with superoxide, tissue damage [62] as evident in our histopathological findings or may be transformed into the more stable hydrogen peroxide radical [62] . Furthermore, NOx itself is considered as a free radical gas and plays an important role in carboplatininduced oxidative stress was demonstrated in table 3 and groups II & III. Nitric oxide, rather than its oxidative effect, plays a major role in occurrence of apoptosis [63] and has proinflammatory effects by increasing cytokine expression raising the concept that inhibition of NO pathways is mostly fruitful in the treatment of inflammation [64] . A positive correlation between NOx production and increased pro-inflammatory cytokine levels (IL-1 & IL-6& TNF-α) were reported in Carboplatin treated rats [65] and demonstrated in present study in groups II& III.
Nitric oxide production can be controlled via positive feedback loop which uses the increase in cAMP levels to activate the production of NOS and subsequent increase in NOx production which stimulate the production of IL-6 & TNF-α by both macrophages and neutrophils [66] . The release of such cytokines can stimulate NOS, leading to further NOx production and increased phagocytosis [66] .
The Consequently, this study assessed the association between CRP and NOx production in groups II,
III, IV and V . This in agreement with studies
showing CRP can induce NOx production by neutrophils in both the presence and absence of infection [67] .
Furthermore, it was manifest in group VII that L-NAME exhibit beneficial effects on hematopoietic system by increasing RBCs, Hb%, PCV and platelet count against Carboplatininduced hematotoxicity markers. Elevation of erythrocyte count by L-NAME might be related to either stimulation of erythropoiesis or prevention of bone marrow suppression or the ability of L-NAME as a free radical scavenging action that reduces leakage of enzymes into blood stream and stabilizes membrane permeability [68] . In addition, L-NAME administration had significant antioxidant effects by a decline in MDA and elevation in SOD, CAT and GSH-Px in Carboplatin -treated rats (group VII). The results of our study were in agreement with previous studies [68] which had proved that L-NAME demonstrated antioxidant action on cerebral tissues, liver, and jejunum but, our data were in contrarily with the results by Selamoglu et al. [69] who showed that L-NAME in the liver may enhance oxidative stress via inhibited nitric oxide synthase.
The anticytokines effects of L-NAME were manifest in group VII which showed a specific significant decrease in IL-1 rather than other plasma inflammatory markers. Nevertheless, variations in the results in vitamin C and L-NAME groups did not demonstrate a significant difference, which may be due to their similar antioxidant and anti-inflammatory properties. 
Conclusion
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